PERTZYE

Drug Chiesi USA, Inc.
Total Payments
$209,477
Transactions
1,253
Doctors
383
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2023 $3,722 54 33
2022 $3,225 233 79
2021 $5,843 244 89
2020 $634.48 48 35
2019 $31,000 267 123
2018 $40,187 170 95
2017 $124,866 237 105

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $122,100 52 58.3%
Food and Beverage $33,219 588 15.9%
Travel and Lodging $19,247 75 9.2%
Space rental or facility fees (teaching hospital only) $16,562 17 7.9%
Consulting Fee $7,285 3 3.5%
Charitable Contribution $5,750 4 2.7%
Education $5,314 514 2.5%

Top Doctors Receiving Payments for PERTZYE — Page 16

Doctor Specialty Location Total Records
, MD, MS Pediatrics New York, NY $9.21 3
, APRN Family Tulsa, OK $6.86 4
, FNP-BC Family Medicine Albuquerque, NM $6.71 2
, ACNP Acute Care Tyler, TX $5.44 2
, M.D Allergy & Immunology Tulsa, OK $5.18 3
, MD Pediatric Pulmonology Grand Rapids, MI $3.75 1
, M.D Pediatric Pulmonology East Brunswick, NJ $3.09 2
Stephanie Myers Registered Nurse Tulsa, OK $2.76 3
, M.D Pediatric Pulmonology Newark, NJ $1.03 1

About PERTZYE

PERTZYE is a drug associated with $209,477 in payments to 383 healthcare providers, recorded across 1,253 transactions in the CMS Open Payments database. The primary manufacturer is Chiesi USA, Inc..

Payment data is available from 2017 to 2023. In 2023, $3,722 was paid across 54 transactions to 33 doctors.

The most common payment nature for PERTZYE is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($122,100, 58.3% of total).